Anti-cancer slow-release agent carried with glucocorticoid hormone and chemical therapy medicine
A technology of glucocorticoids and corticosteroids, which is applied in the direction of drug combination, drug delivery, and non-active components of polymer compounds, can solve problems such as increased resistance of anticancer drugs, limitation of effective drug diffusion, and obstacles to tumor chemotherapy. Improve the conductivity of interstitial fluid, inhibit the formation of new blood vessels, and facilitate the effect of penetration and diffusion
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0147] Put 80 parts of polyphenylpropane (p-carboxyphenylpropane (p-CPP): sebacic acid (SA) at 20:80) copolymer into a container, add 100 ml of dichloromethane, dissolve and mix well, then add 10 parts of dexamethasone and 10 parts of 7-hydroxyl-staurosporine, shake up again and prepare the injection containing 10% dexamethasone and 10% 7-hydroxyl-staurosporine with spray drying method Microspheres. Then suspend the microspheres in physiological saline containing 15% mannitol to prepare the corresponding suspension-type sustained-release injection. The drug release time of the slow-release injection in the physiological saline in vitro is 30-55 days, and the drug release time in the mouse subcutaneous is about 30 days.
Embodiment 2
[0149] The method step of being processed into sustained-release injection is the same as that of Example 1, but the difference is that polyphenylene is 50:50; the contained anticancer active ingredient and its weight percentage are: 0.1-10% prednisolone, Methylprednisolone, dexamethasone, betamethasone, triamcinolone, or triamcinolone acetonide with 1-40% of 7-hydroxyl-staurosporine, 7-O-alkylstaurosporine, beta - a combination of methoxystaurosporine, alkylphosphocholine or hexadecylphosphorylcholine.
Embodiment 3
[0151] 80 mg of polylactic acid (PLA) with a peak molecular weight of 20,000-40,000 is put into a container, 100 ml of methylene chloride is added, after dissolving and mixing, 5 mg of prednisolone and 15 mg of 7-ethyl-10-hydroxycamptothecin are added, Shake again and dry in vacuo to remove the organic solvent. The dried drug-containing solid composition is frozen and pulverized to make micropowder containing 5% prednisolone and 15% 7-ethyl-10-hydroxycamptothecin, and then suspended in 1.5% sodium carboxymethylcellulose In physiological saline, the corresponding suspension-type sustained-release injection was prepared. The drug release time of the slow-release injection in physiological saline in vitro is 20-35 days, and the drug release time in mice subcutaneous is about 35-50 days.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com